Smoking Objective of 'Healthy People 2000' Is Probably Not Attainable

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 6
Volume 4
Issue 6

WASHINGTON--The US Public Health Service's 10-year plan for improving Americans' health, dubbed Healthy People 2000, will be a disappointment to antismoking forces. The goal--to decrease the number of smokers to only 15% of the population--will not be reached, and it is likely that 20% of Americans will still be smoking by the end of the century. "We're talking about a lot of people who are going to die," said Harold Freeman, MD, chairman of the President's Cancer Panel.

WASHINGTON--The US Public Health Service's 10-year plan for improvingAmericans' health, dubbed Healthy People 2000, will be a disappointmentto antismoking forces. The goal--to decrease the number of smokersto only 15% of the population--will not be reached, and it islikely that 20% of Americans will still be smoking by the endof the century. "We're talking about a lot of people whoare going to die," said Harold Freeman, MD, chairman of thePresident's Cancer Panel.

Currently, 80 clinical trials are underway in which gene therapyis being used to treat genetic diseases, AIDS, and several typesof cancer. The newly issued patent will cover most of these trials.

Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Related Content